Search clinical trials for: TAR-DNA-binding protein-43
Total 20579 results
-
University of UtahCompletedAtrial FibrillationUnited States
-
Protein Supplies SLWithdrawn
-
Protein Supplies SLCompleted
-
Protein Supplies SLUnknownObesity, Morbid | Bariatric Surgery | Comorbidity
-
Protein Sciences CorporationCompleted
-
Protein Sciences CorporationCompleted
-
Protein Sciences CorporationCompleted
-
University Hospital, ToulouseCompleted
-
University of PittsburghCompleted
-
University of SurreyEuropean UnionCompletedOverweight | Iron-deficiency | Nutritional Deficiency | Poor NutritionUnited Kingdom
-
Musclegen Research, Inc.CompletedAbsorption; Disorder, Protein | Analysis, Event History
-
National Cancer Institute (NCI)CompletedTongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditionsUnited States
-
FHI 360Ministry of Health, Chile; Chilean Institute of Reproductive MedicineCompleted
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
National Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma | Stage IA Malignant Mesothelioma | Stage IB Malignant Mesothelioma | Stage II Malignant Mesothelioma | Stage III Malignant Mesothelioma | Stage IV Malignant MesotheliomaUnited States
-
University of BolognaNovartisCompleted
-
Charite University, Berlin, GermanyCompleted
-
Chengdu CoenBiotech Co., LtdBeijing Friendship Hospital; Beijing Chest Hospital, Capital Medical UniversityCompleted
-
University of HohenheimCompleted
-
Memorial Sloan Kettering Cancer CenterBayerCompletedEsophageal Cancer | Gastroesophageal Junction CancerUnited States
-
University of PittsburghCompletedEmesisUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedSorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryStage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
University of TorontoCompletedProtein/Amino Acid Metabolism | Indicator Amino Acid Oxidation MethodCanada
-
SanofiProtein Sciences CorporationCompletedInfluenzaUnited States
-
Tulane UniversityIdeal ProteinCompletedWeight LossUnited States
-
Singapore Institute of TechnologyAMILI Pte. Ltd.Active, not recruitingGastrointestinal Microbiome | Protein DigestionSingapore
-
Wageningen University and ResearchCompletedProtein Digestion Kinetics | Intestinal Barrier FunctionNetherlands
-
Rajavithi HospitalRecruitingPostoperative Outcomes | Whey Protein | Gynecological Cancer SurgeryThailand
-
Charite University, Berlin, GermanyTerminatedPatients Following Gastrointestinal SurgeryGermany
-
Federal University of UberlandiaNot yet recruiting
-
Tanta UniversityNot yet recruitingSodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
-
HealthBanks Biotech Co., Ltd.UnknownPhase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein VaccineCervical Intraepithelial Neoplasia
-
University of HohenheimUniversity Hospital TuebingenCompletedBariatric Surgery CandidateGermany
-
University Hospital, Strasbourg, FranceRecruitingResistance to Activated Protein C in the Determination of Protein S ActivityFrance
-
UConn HealthTerminatedBreast NeoplasmsUnited States
-
General Hospital of Ningxia Medical UniversityCompletedPostoperative Complications | Cognitive Dysfunction | Inflammasomes | Pyrin Domain-Containing 3 ProteinChina
-
University of ChicagoBayerCompletedPulmonary Arterial HypertensionUnited States
-
Istituto Clinico HumanitasCompletedCarcinoma, HepatocellularItaly
-
University of WashingtonNational Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayer; United States Department of DefenseCompleted
-
British Columbia Cancer AgencyCompletedAdenocarcinoma of the ProstateCanada
-
Janssen Vaccines & Prevention B.V.Completed
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedTumors Metastatic to BrainUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States